The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Salmeterol response is not affected by beta(2)-adrenergic receptor genotype in subjects with persistent asthma.

BACKGROUND: Recent studies suggest that there might be an association between albuterol use and worsening asthma in patients homozygous for arginine (Arg/Arg) at codon 16 of the beta-receptor. However, it is not known whether similar responses occur in Arg/Arg patients receiving long-acting beta(2)-agonists. OBJECTIVE: We sought to evaluate the effects of variation in the beta(2)-adrenergic receptor gene (ADRB2) on clinical response to salmeterol administered with fluticasone propionate. METHODS: Subjects (n = 183) currently receiving short-acting beta(2)-agonists were randomized to twice-daily therapy with salmeterol, 50 mug, administered with fluticasone propionate, 100 mug, in a single inhaler or daily therapy with montelukast for 12 weeks, followed by a 2- to 4-day run-out period. RESULTS: There was sustained and significant improvement (P < .001) over baseline in all measures of asthma control in subjects receiving salmeterol, regardless of Arg16Gly genotype. Morning peak expiratory flow in subjects with the Arg/Arg genotype showed 89.0 +/- 16.1 L/min improvement over baseline compared with 93.7 +/- 12.7 L/min for Gly/Gly subjects and 92.5 +/- 11.9 L/min for Arg/Gly subjects. Pairwise changes were similar for Arg/Arg compared with Gly/Gly or Arg/Gly genotypes (estimated differences, 4.7 L/min and 3.5 L/min, respectively). Responses did not appear to be modified by haplotype pairs. During the run-out period, all subjects had predictable and similar decreases in measures of asthma control, with no differences between genotypes. CONCLUSION: Response to salmeterol does not vary between ADRB2 genotypes after chronic dosing with an inhaled corticosteroid. CLINICAL IMPLICATIONS: Analyses from this study indicate that genetic polymorphisms leading to Arg16Gly sequence changes within the beta(2)-adrenergic receptor do not affect patients' responses to recommended asthma therapy with salmeterol and fluticasone propionate.[1]


  1. Salmeterol response is not affected by beta(2)-adrenergic receptor genotype in subjects with persistent asthma. Bleecker, E.R., Yancey, S.W., Baitinger, L.A., Edwards, L.D., Klotsman, M., Anderson, W.H., Dorinsky, P.M. J. Allergy Clin. Immunol. (2006) [Pubmed]
WikiGenes - Universities